A new study published in Clinical Infectious Diseases highlights the potential of pemivibart, a long-acting monoclonal ...

(Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the SPEAR (Spike Protein Elimination and Recovery) Study Group. The ...

The global monoclonal antibodies in veterinary health market size was US$ 671.6 million in 2021. The global monoclonal antibodies in veterinary health market are expected to grow to US$ 2371.1 million ...

For infants born from October to February, maternal vaccination was cost-effective, but compared with vaccination, nirsevimab ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

Indian scientists discover cancer drug SB431542 effectively fights COVID-19, showing potential to prevent virus resistance in ...

The first paper from a multi-year clinical research study has been published in The Lancet Infectious Diseases. The article ...

The first paper from a multi-year clinical research study has been published in The Lancet Infectious Diseases: Dynamics of ...

HHS Secretary Robert F. Kennedy Jr. last month quietly endorsed recommendations from his handpicked vaccine advisors that ...

Note that some links may require registration or subscription. HHS Secretary Robert F. Kennedy Jr. announced that 22 projects ...

Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the ...